上一条： Discovery of novel fused-heterocycle-bearing diarypyrimidine derivatives as HIV-1 potent NNRTIs targeting tolerant region I for enhanced antiviral activity and resistance profile

下一条： Targeting novel sites represents an effective strategy for combating drug resistance